In a development pregnant with possibilities, U.S. Trade Representative Robert Lighthizer stated, the Wuhan Coronavirus pandemic shows that the United States is way too dependent on cheap foreign imports for key strategic medical supplies. The statement underscores the need for… Read More ›
key
Japan second biggest drugmaker Astellas Pharma to acquire Audentes Therapeutics for $3 billion
Japan’s Astellas Pharma Inc is set to acquire Audentes Therapeutics Inc for around $3 billion in a deal aimed at boosting genetic medicines – a key area of growth. Gene therapies are one of the hottest areas of drug research…. Read More ›
Japan to increase scrutiny on foreign ownership of Japanese firms
Japan is taking steps to improve the monitoring of the ownership of its companies in industries which it considers as critical to its national security. According to two officials with knowledge of the matter at hand, Japanese officials are considering… Read More ›